Home > Magazine > Society

Complete List of 2011 Conquer Cancer Foundation Grants and Awards Recipients

Jun 13, 2011

Community Oncology Research Grant (CORG)

Cancer Care Specialists of Central Illinois
Decatur, Illinois

Newark Beth Israel Medical Center
Newark, New Jersey

The Valley Hospital
Ridgewood, New Jersey

Clinical Trials Participation Award

Children’s Hospital of New Orleans/LSUHSC
New Orleans, Louisiana

Cooper Cancer Institute
Voorhees, New Jersey

Florida Cancer Specialists and Research Institute
Sarasota, Florida

Missouri Baptist Medical Center
St. Louis, Missouri

Northeast Radiation Oncology Center (NROC)
Dunmore, Pennsylvania

St. Joseph Hospital of Orange
Orange, California
State Affiliate Grant

Florida Society of Clinical Oncology
"End of Life Initiative:A Training program for the development of ARNP/PA-coordinated early palliative care consultation services for metastatic cancer patients"

Georgia Society of Clinical Oncology
"Creation of Electronic Working Groups to Improve Quality of Care through Enhanced Collaboration Between Georgia's Academic Medical Centers and Community Based Oncology Providers"

Michigan Society of Hematology & Oncology
"Oral Therapies: Optimizing Existing Resources for Patient Safety, Adherence and Outcomes"

New Mexico Society of Clinical Oncology
"Enhancing Cultural Sensitivity Training for Oncologists in New Mexico"

Tennessee Oncology Practice Society
"TOPS Initiative to Develop State-Wide Cancer Treatment Protocols for Private Payer Use and a Mechanism for Monitoring Compliance"

Young Investigator Award (YIA)

Fernanda Arnaldez, MD
National Cancer Institute
“Identification of Alveolar Rhabdomysarcoma ‘Achilles’ Heel’”

Chloe Atreya, MD, PhD
University of California, San Francisco
“Mutational Analysis of Metastatic Colorectal Cancer: Determination of the Frequency and Distribution of Mutations in Liver Metastases; and Development plus Pharmacogenomic Testing of a Novel, Isogenic Colon Cancer Model”

Davide Bedognetti, MD
National Institutes of Health
“Genomic, Functional Genomics and Proteomics Signature in Advanced Ovarian Cancer Patients and Their Prognostic and/or Predictive Implications”

Erin Bertino, MD
The Ohio State University
“Enhancement of Cetuximab-induced Antibody-Dependent Cellular Cytotoxicity (ADCC) with Lenalidomide in Advanced Solid Tumors: A Phase I Study"

Uma Borate, MD
University of Alabama at Birmingham
"Measurement of Extracellular Telomeres as a Novel Biomarker of in vivo Apoptosis in Patients with Acute Myeloid Leukemis (AML)"

Edward Cha, MD, PhD
University of California, San Francisco
“Determining the Kinetics of T Cell Activation and Antigen-specific Recognition with Ipilimumab and GM-CSF in Melanoma”

Jamie Chaft, MD
Memorial Sloan-Kettering Cancer Center
“Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus”

Jane Churpek, MD
The University of Chicago
“Identification of Hematologic Malignancy Predisposition Genes by Whole Exome Sequencing of High Risk Families”

Elizabeth Comen, MD

Memorial Sloan-Kettering Cancer Center
“The Evaluation of the Cytotoxicity of Select Neutrophils in Inhibiting Metastatic Breast”

Sandra D’Angelo, MD
Memorial Sloan-Kettering Cancer Center
‘Enhancing the Activity of Temozolomide for the Treatment of Stage Small Cell Lung Cancer by Addition of the PARP-1 Inhibitor Veliparib (ABT-888)”

Dustin Deming, MD
University of Wisconsin
“Development of a Novel Mouse Model of Human Colorectal Cancer for Screening Target-directed Pharmacologic Agents”

Leslie Doros, MD
Children’s National Medical Center
“Clinical Investigation of the Pleuropulmonary Blastoma (PPB) Family Cancer Syndrome”

Michael Eckrich, MD, MPH
Medical College of Wisconsin
“Association of Pediatric Transplant Center Characteristics and Physician Factors on Survival after Hematopoietic Stem Cell Transplantation in the United States”

Clifton Fuller, MD
Oregon Health & Science University
“Development and Randomized Prospective Validation of a Consensus Atlas for Radiotherapy Target Definition in Cholangiocarcinoma and Gallbladder Cancers”

Stephanie Gaillard, MD, PhD
Johns Hopkins University
"The Role of SYK in the Development of Chemoresistance in Ovarian Serous Carcinoma"

Tara Gangadhar, MD
The University of Chicago
“A Pharmacologic and Pharmacodynamic Modeling Approach for Developing Safe Combination Therapy with Vorinostat and Carboplatin”

Kathryn Ann Gold, MD
University of Texas, M.D. Anderson Cancer Center
"The Epithelial-Mesenchymal Transition, the MicroR-NA-200 Family, and Chemosensitivity in Lung Cancer"

Ayca Gucalp, MD
Memorial Sloan-Kettering Cancer Center
“Targeting the Androgen Receptor Signaling Pathway for the Treatment of Advanced Breast Cancer”

Peter Hammerman, MD, PhD
Dana Farber Cancer Institute
“Investigating DDR2 Mutations as a Potential Therapeutic Target in Squamous Cell Lung Cancer”

John Hays, MD, PhD
National Cancer Institute
"Partial Least Squares Regression Analysis Predicts Targetable Network Signaling Nodes in the Tumor Microenvironment"

Thai Ho, MD, PhD
The University of Texas M. D. Anderson Cancer Center
“The Role of SETD2, a Histone Methyltransferase, in the Development of Renal Cell Carcinoma”

Samantha Jaglowski, MD
The Ohio State University
“A Phase Ib/II Study of PCI-32765, a Btk-inhibitor, and Ofatumumab in Patients with Relapsed/Refractory Chronic lymphocytic Leukemia/Small Lymphocytic Lymphoma and Related Diseases”

Raymond Jang, MD
University of Toronto
“The Impact of Palliative Care on the Trajectory of Patients with Advanced Cancer Who Received Chemotherapy Within 14 Days of Death”

Komal Jhaveri, MD
Memorial Sloan-Kettering Cancer Center
“Increasing Efficiency of Drug Development with a Targeted Imaging Strategy: First-in-human Phase I Trial of PU-H71, a Novel HSP90 Inhibitor with 124I-PU-H71 for the Treatment of Advanced Malignancies”

Belinda Kiely, MD
NHMRC Clinical Trials Centre, University of Sydney
“Evaluating an iTool to Estimate and Explain Survival Time Scenarios to People with Advanced Cancer”

Jung-min Lee, MD
National Cancer Institute
“Sequence Specific DNA Damage with PARP Inhibition and Carboplatin”

Christine Lovly, MD, PhD
Vanderbilt University
“Defining Mechanisms of Acquired Resistance to ALK Tyrosine Kinase Inhibitors”

Jason Luke, MD
Memorial Sloan-Kettering Cancer Center
”Examination of the Molecular and Therapeutic effects of mTOR and PDGFRA inhibition in Advanced Synovial Sarcoma”

Erminia Massarelli, MD, PhD
The University of Texas M. D. Anderson Cancer Center
“Role of CXCR2 Inhibitors in Non-small Cell Lung Cancer”

Nathalie McKenzie , MD
University of Miami Miller School of Medicine
“Addition of Nelfinavir, a Biologic Radiosensitizer, to Improve the Efficacy of Chemoradiation in Locally Advanced Cervical Cancer”

Jason Mendler, MD, PhD
The Ohio State University
“Identification of Functionally Important MicroRNAs in Poor-risk Acute Myeloid Leukemia”

Andres Morales La Madrid, MD
The University of Chicago
“Genome-based Outcome Prediction in High-risk Neuroblastoma”

Patrick Morris, MD
Memorial Sloan-Kettering Cancer Center
“Association of Smoking, Lung Inflammation and Lung Metastases from Breast Cancer”

Deepak Nijhawan, MD, PhD
Dana-Farber Cancer Institute
“Identifying Cancer Targets in Regions of Broad Genomic Amplification in Lung Cancer”

Stephen Oh, MD, PhD
Washington University in St. Louis
“Functional Characterization of LNK Mutations in Myeloproliferative Neoplasms”

Paul Paik, MD
Memorial Sloan-Kettering Cancer Center
“Characterization of the Molecular Heterogeneity of EGFR Mutant Lung Adenocarcinoma: Baseline and Post-Treatment Tumor Analysis”

Channing Paller, MD
Johns Hopkins University
“Evaluation of Muscadine Grape Skin Powder as a Novel Antitumor Agent in Men with Rising PSA after Primary Therapy for Prostate Cancer”

Jae Park, MD
Memorial Sloan-Kettering Cancer Center
“Consolidative Adoptive Immunotherapy of B-Cell Leukemia With Genetically Modified Autologous T Cells”

Chad Pecot, MD
The University of Texas M. D. Anderson Cancer Center
“Therapeutic miRNA targeting for Lung Cancer Metastases”

Wiliam Polkinghorn, MD
Memorial Sloan-Kettering Cancer Center
“Defining the Role of AR Signaling in Promoting Prostate Cancer Radioresistance”

Albiruni Ryan Abdul Razak, MBBCh, MRCPI, CCT
Princess Margaret Hospital
"The Role of Urinary NGAL, KIM-1 and IL-18 as Predictive Biomarkers for Proteinuric Renal Disease and Hypertension Associated with Anti-angiogenic Therapy"

Flavio Rocha, MD
Memorial Sloak-Kettering Cancer Center
” CEACAM6 as a Biologic Marker and Prognostic Factor of Biliary Malignancy”

Nilay Shah, MD
Johns Hopkins University
“Aberrant HOX Gene and Hox-associated Noncoding RNA Expression in Aggressive Neuroblastoma”

Stephen Shiao, MD, PhD
University of California, San Francisco
“Effects of Combining Chemotherapy and Radiation with IL-4 Inhibition on Breast Cancer Progression in a Murine Model of Breast Cancer”

Davendra Sohal, MD, MPH
University of Pennsylvania
“Identifying Molecular Predictors in Advanced Cholangiocarcinoma”

Sarah Tasian, MD
University of California, San Francisco
“Predicting Biochemical and Genetic Responses to JAK Inhibitor Therapy in Patients with CRLF2-Overexpressing Acute Lymphoblastic Leukemia”

David Tran, MD, PhD
Washington University
“Breaking Cancer Dormancy To Sensitize Dormant Breast Cancer Cells to Cytotoxic Chemotherapy”

Eduardo Vilar-Sanchez, MD, PhD
University of Michigan
“Developing Targeted Therapies for Microsatellite Instable Colorectal Cancers”

Liza Villaruz, MD
University of Pittsburgh
“Differential MicroRNA Expression and Response to Carboplatin/Paclitaxel-Based Chemotherapy in Patients with Metastatic Melanoma”

Philip Wong, MD
Princess Margaret Hospital
“Identifying mRNA and micro-RNA Signatures in Soft-Tissue Sarcomas”

Jennifer Woyach, MD
The Ohio State University
“A Phase I Study of Carfilzomib in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Leukemia (PLL)”

Xunhai Xu, MD
Columbia University Medical Center
“Evaluating Blood-based Biomarkers in Patients Treated with an AKT Inhibitor (MK-2206) in a Pre-Surgical Model”

Career Development Award (CDA)

Daniel Anaya, MD
Baylor College of Medicine
“Postoperative Transitional and Health-related Quality of Life Outcomes in Elderly Patients with Colorectal Cancer”

Tracy Balboni, MD, MPH
Dana-Farber Cancer Institute
“Examining How Religiousness and Spiritual Care affect Quality of Life and Medical Care of Cancer Patients near Death”

David Buchbinder, MD, MS
CHOC Children’s Hospital / University of California, Irvine
“Psychosocial Outcomes of Siblings of Pediatric Stem Cell Transplant Survivors”

Mark A. Dickson, MD
Memorial Sloan-Kettering Cancer Center
"A Phase II Study of PD0332991 in Liposarcoma with CDK4 Amplification"

Mehdi Hamadani, MBBS
West Virginia University
"Atorvastatin for the Prophylaxis of Acute Graft-versus-Host-disease in Patients Undergoing Matched Sibling Allogenic Transplantation"

Yubin Kang, MD
Medical University of South Carolina
“A Phase I/II Study: Enhancing Donor Cell Engraftment with CXCR4 Antagonist in Hematopoietic Stem Cell Transplantation”

Nicholas Mitsiades, MD, PhD
Baylor College of Medicine
“Investigation of the Anticancer Activity of Meformin and Statins in Prostate Cancer"

Benjamin Smith, MD
The University of Texas M.D. Anderson Cancer Center
“Randomized Trial of Hypofractionated Whole Breast Irradiation versus Conventionally Fractionated Whole Breast Irradiation for Ductal Carcinoma in Situ and Early Invasive Breast Cancer”

Ryan Sullivan, MD
Beth Israel Deaconess Medical Center
“Exploring the Utility of a Novel BRAF Test in Patients with Melanoma”

Raoul Tibes, MD, PhD
Mayo Clinic, Arizona
“RNAi Lethality Screening in Leukemias Identifies WEE1 Kinase Inhibition as Potent Sensitizer to Cytarabine – A Phase I Clinical Trial and Correlative Laboratory Studies”
Merit Award

Bradley Stuart Beller Special Merit Award
Fabiola Cecchi, MD
National Cancer Institute, National Institutes of Health

Brigid Leventhal Special Merit Award
Daniel Weiser, MD
The Children’s Hospital of Philadelphia

View the complete list of 2011 ASCO Annual Meeting Merit Award Winners.

Back to Top